Supernus adds epilepsy candidate with $185M Biscayne buy

Supernus adds epilepsy candidate with $185M Biscayne buy

Submitted by admin on September 16, 2018 - 2:24pm
Source: 
Fierce Biotech
News Tags: 
Supernus
M&A
Biscayne Neurotherapeutics
epilepsy
Headline: 
Supernus adds epilepsy candidate with $185M Biscayne buy
snippet: 

CNS drug specialist Supernus Pharma has added an early-stage epilepsy candidate to its pipeline after paying $15 million upfront to acquire Biscayne Neurotherapeutics.

Do Not Allow Advertisers to Use My Personal information